Assessment of Prosthetic Valve Function After TAVR

Sorin V. Pislaru, Vuyisile T Nkomo, Gurpreet S. Sandhu

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Calcific aortic valve stenosis is a common valve pathology that increases in prevalence with advancing age. Transcatheter aortic valve (TAV) replacement has now emerged as the preferred treatment for patients at high risk for surgery and for those who are inoperable. However, the use of this ground-breaking technology has inevitably been associated with a host of new problems. These new types of complications are frequently unrecognized or underestimated due to lack of familiarity with the normal and pathological appearance of TAV and often require redefining strategies for diagnosis and treatment. This review presents a systematic approach for follow-up assessment of TAV function, as well as pathology uniquely related to TAV. Because the worldwide transcatheter aortic valve replacement experience has been dominated by the Edwards Sapien (Irvine, California) and Medtronic CoreValve (Minneapolis, Minnesota) family of bioprosthetic aortic valves, we will focus our review on these valves, each with their unique set of advantages and technological challenges.

Original languageEnglish (US)
Pages (from-to)193-206
Number of pages14
JournalJACC: Cardiovascular Imaging
Volume9
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Aortic Valve
Pathology
Aortic Valve Stenosis
Technology
Therapeutics
Transcatheter Aortic Valve Replacement

Keywords

  • aortic stenosis
  • echocardiography
  • imaging
  • transcatheter aortic valve replacement

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Assessment of Prosthetic Valve Function After TAVR. / Pislaru, Sorin V.; Nkomo, Vuyisile T; Sandhu, Gurpreet S.

In: JACC: Cardiovascular Imaging, Vol. 9, No. 2, 01.02.2016, p. 193-206.

Research output: Contribution to journalReview article

Pislaru, Sorin V. ; Nkomo, Vuyisile T ; Sandhu, Gurpreet S. / Assessment of Prosthetic Valve Function After TAVR. In: JACC: Cardiovascular Imaging. 2016 ; Vol. 9, No. 2. pp. 193-206.
@article{56a62e4c0b254ba8b03ce0556b13a6bb,
title = "Assessment of Prosthetic Valve Function After TAVR",
abstract = "Calcific aortic valve stenosis is a common valve pathology that increases in prevalence with advancing age. Transcatheter aortic valve (TAV) replacement has now emerged as the preferred treatment for patients at high risk for surgery and for those who are inoperable. However, the use of this ground-breaking technology has inevitably been associated with a host of new problems. These new types of complications are frequently unrecognized or underestimated due to lack of familiarity with the normal and pathological appearance of TAV and often require redefining strategies for diagnosis and treatment. This review presents a systematic approach for follow-up assessment of TAV function, as well as pathology uniquely related to TAV. Because the worldwide transcatheter aortic valve replacement experience has been dominated by the Edwards Sapien (Irvine, California) and Medtronic CoreValve (Minneapolis, Minnesota) family of bioprosthetic aortic valves, we will focus our review on these valves, each with their unique set of advantages and technological challenges.",
keywords = "aortic stenosis, echocardiography, imaging, transcatheter aortic valve replacement",
author = "Pislaru, {Sorin V.} and Nkomo, {Vuyisile T} and Sandhu, {Gurpreet S.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.jcmg.2015.11.010",
language = "English (US)",
volume = "9",
pages = "193--206",
journal = "JACC: Cardiovascular Imaging",
issn = "1936-878X",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Assessment of Prosthetic Valve Function After TAVR

AU - Pislaru, Sorin V.

AU - Nkomo, Vuyisile T

AU - Sandhu, Gurpreet S.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Calcific aortic valve stenosis is a common valve pathology that increases in prevalence with advancing age. Transcatheter aortic valve (TAV) replacement has now emerged as the preferred treatment for patients at high risk for surgery and for those who are inoperable. However, the use of this ground-breaking technology has inevitably been associated with a host of new problems. These new types of complications are frequently unrecognized or underestimated due to lack of familiarity with the normal and pathological appearance of TAV and often require redefining strategies for diagnosis and treatment. This review presents a systematic approach for follow-up assessment of TAV function, as well as pathology uniquely related to TAV. Because the worldwide transcatheter aortic valve replacement experience has been dominated by the Edwards Sapien (Irvine, California) and Medtronic CoreValve (Minneapolis, Minnesota) family of bioprosthetic aortic valves, we will focus our review on these valves, each with their unique set of advantages and technological challenges.

AB - Calcific aortic valve stenosis is a common valve pathology that increases in prevalence with advancing age. Transcatheter aortic valve (TAV) replacement has now emerged as the preferred treatment for patients at high risk for surgery and for those who are inoperable. However, the use of this ground-breaking technology has inevitably been associated with a host of new problems. These new types of complications are frequently unrecognized or underestimated due to lack of familiarity with the normal and pathological appearance of TAV and often require redefining strategies for diagnosis and treatment. This review presents a systematic approach for follow-up assessment of TAV function, as well as pathology uniquely related to TAV. Because the worldwide transcatheter aortic valve replacement experience has been dominated by the Edwards Sapien (Irvine, California) and Medtronic CoreValve (Minneapolis, Minnesota) family of bioprosthetic aortic valves, we will focus our review on these valves, each with their unique set of advantages and technological challenges.

KW - aortic stenosis

KW - echocardiography

KW - imaging

KW - transcatheter aortic valve replacement

UR - http://www.scopus.com/inward/record.url?scp=84977605248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977605248&partnerID=8YFLogxK

U2 - 10.1016/j.jcmg.2015.11.010

DO - 10.1016/j.jcmg.2015.11.010

M3 - Review article

C2 - 26846938

AN - SCOPUS:84977605248

VL - 9

SP - 193

EP - 206

JO - JACC: Cardiovascular Imaging

JF - JACC: Cardiovascular Imaging

SN - 1936-878X

IS - 2

ER -